The AVITA as seen in an image from an Element Biosciences 3D demo. Photo credit: elementbiosciences.com/3d-virtual-demo San Diego’s Element Biosciences has announced over $277 million in Series D investment to support its growing customer base with DNA sequencing and other technologies. The oversubscribed round was led by Wellington Management with participation from new and existing investors, including Samsung Electronics, Fidelity, Foresite Capital, funds and accounts advised by T. Rowe Price Associates, Inc, and Venrock, among others. This brings the Sorrento Valley-based firm’s cumulative raise to over $680 million, the company said in a news release. “After years of watch
Hence then, the article about element with dna sequencer praised as foundational to biotech innovation raises 277m was published today ( ) and is available onTimes of San Diego ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Element, with DNA Sequencer Praised As ‘Foundational’ to Biotech Innovation, Raises $277M )